前列舒通胶囊联合非那雄胺治疗前列腺增生的疗效观察

Efficacy of BPH Capsule Qianlieshu Joint Finasteride Therapy

目的观察前列舒通胶囊联合非那雄胺治疗前列腺增生的临床疗效。方法选取符合诊断标准57例患者,随机分为对照组(27例)和观察组(30例)。对照组给予非那雄胺治疗,观察组联合应用前列舒通胶囊和非那雄胺治疗。在治疗前和治疗3个月后分别观察临床疗效,相关指标改善情况。结果与对照组相比,观察组治疗前后国际前列腺症状评分(IPSS)、残余尿量(Ru)、前列腺体积(PV)等指标显著降低。最大尿流率(Qmax)明显升高。结论前列舒通胶囊联合非那雄胺治疗疗效可靠,能够显著提高临床疗效,改善临床指标且不良反应轻微。

Objective To observe the clinical effect of the combination of Qianlieshutong capsule with Finasteride for the treatment of the patients who had suffered prostatic hyperplasia. Methods 57 patients were randomly divided into two groups, control group （27 cases） and the observation group （30 cases）. The control group was treated with Finasteride, and the observation group was treated by the combination of Qianlieshutong capsule with Finasteride, The clinical effects and the improvement of the related indicators were examined and observed before and after 3 months of treatment. Results Compared with the control group, the International Prostate Symptom Score （IPSS）, residual urine volume （Ru）, prostate volume （PV） were significantly lower than the control group. The maximum urinary flow rate （Qmax） was significantly elevated. Conclusion The combined treatment of the patients with Qianlieshutong capsule with Finasterid is reliable, and can improve the clinical effect, and the improvement of the clinical index and the side effect is mild.